{
    "eid": "2-s2.0-85133931178",
    "title": "Perampanel as adjunctive therapy in drug resistant epilepsy in adolescents and children waiting for epilepsy surgery: A multicenter observational study in Thailand",
    "cover-date": "2022-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Anti-seizure medication",
        "Drug-resistant",
        "Epilepsy",
        "Perampanel",
        "Treatment-resistant"
    ],
    "authors": [
        "Piradee Suwanpakdee",
        "Burachat Saksritavee",
        "Napakjira Likasitthananon",
        "Thitiwan Simasathien",
        "Tayard Deesudchit",
        "Chaiyos Khongkhatithum",
        "Sorawit Viravan",
        "Charcrin Nabangchang"
    ],
    "citedby-count": 2,
    "ref-count": 32,
    "ref-list": [
        "Incidence, prevalence and aetiology of seizures and epilepsy in children",
        "Risk factors for drug-resistant epilepsy: a systematic review and meta-analysis",
        "Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis",
        "Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies",
        "The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis",
        "What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture",
        "Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA)",
        "Clinical management of drug resistant epilepsy: a review on current strategies",
        "Managing drug-resistant epilepsy: challenges and solutions",
        "Systematic review and meta-analysis of the efficacy and safety of perampanel in the treatment of partial-onset epilepsy",
        "Perampanel as adjunctive therapy in highly refractory epilepsies: real-world data from an Italian tertiary care epilepsy centre",
        "A two-year retrospective evaluation of perampanel in patients with highly drug-resistant epilepsy and cognitive impairment",
        "The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a \"real world\" context: focus on temporal lobe epilepsy",
        "Efficacy and tolerability of adjuvant perampanel: an Australian multicenter real-world observational study in refractory focal and generalized epilepsy syndromes",
        "Perampanel treatment in highly drug-resistant epilepsies including nonsurgical candidates and failed surgery",
        "The efficacy of perampanel in young children with drug-resistant epilepsy",
        "Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences",
        "Clinical experience with perampanel for refractory pediatric epilepsy in one Canadian center",
        "Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy",
        "Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics",
        "ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology",
        "Adjunctive perampanel oral suspension in pediatric patients from\u2265 2 to < 12 years of age with epilepsy: pharmacokinetics, safety, tolerability, and efficacy",
        "Pharmacological treatment of drug-resistant epilepsy in adults: a practical guide",
        "Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action",
        "Antiepileptic drug therapy in patients with drug-resistant epilepsy",
        "The pharmacoresistant epilepsy: an overview on existant and new emerging therapies",
        "Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy",
        "Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up",
        "Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study",
        "Effectiveness and tolerability of Perampanel in children, adolescents and young adults with refractory epilepsy: a UK national multicentre study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}